Deprescribing dRrugs for Overactive Bladder in General Practice (DROP)

Condition(s) studied

Investigational drug(s) / intervention(s)

deprescribing-intervention: The clinical guideline on "Deprescribing drugs for OAB" in The North Denmark Region serves as the basis for the intervention. The guideline provides recommended procedures for the deprescribing process. The guideline offers procedures for the deprescribing process and includes a deprescribing algorithm and a symptom questionnaire designed to evaluate the impact of medications utilized in the treatment of OAB.

Study summary

The objective is to understand and evaluate the effectiveness of a deprescribing intervention in primary care, specifically targeting medications for overactive bladder in individuals aged 65 or older.

Eligibility

Primary outcome measure(s)

• Difference in proportion of patients receiving drugs for overactive bladder — 6 months
  The primary outcome will be the difference in the proportion of patients receiving drugs for overactive bladder before and after a 6-month follow-up period.

Trial sites (1)